Dr. Eric Daniel Schultz, DO

Dr. Schultz practices at Greater Austin Allergy, Asthma & Immunology PA in Austin, Texas.

Dr. Schultz's NPI, 1578774980, was assigned on May 25, 2007. Dr. Schultz graduated from WesternU College of Osteopathic Medicine of the Pacific in 2002. Dr. Schultz holds Texas license N7748.

Dr. Schultz's primary practice is Greater Austin Allergy, Asthma & Immunology PA, at 5656 Bee Cave Rd, Austin, TX 78746 in Travis County. The practice phone is (512) 732-2774.

Dr. Schultz's primary practice is Greater Austin Allergy, Asthma & Immunology PA in Austin, Texas. Dr. Schultz is also affiliated with The Hospital at Westlake Medical Center. The medical group on file is Greater Austin Allergy. Dmand AI also links Dr. Schultz to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schultz practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Schultz's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Schultz is board certified in neonatal-perinatal medicine by the American Board of Pediatrics. Dr. Schultz is licensed in Texas.

Dmand AI lists acid reflux, acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, conjunctivitis, contact dermatitis and hives among the conditions Dr. Schultz treats.

CMS data shows 11,845 Medicare services from Dr. Schultz across 10 procedure codes in 2024, for 240 Medicare patients. Medicare paid $121,125 for them. Every service was in an office.

CMS counts 240 Medicare patients who saw Dr. Schultz in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schultz's median patient age at 46, with 57% women.

In 2024, Dr. Schultz wrote 921 Medicare Part D claims for 168 patients. 49% of them were for generic drugs. CMS names the drug for 743 of them, across 24 drugs with 11 or more claims each, at $840,615 in total drug cost. In 2023, CMS named 590 claims across 22 drugs.

Dr. Schultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schultz as offering telehealth.

Dmand AI links 2 papers to Dr. Schultz. The most frequent topics are Infant, Premature, Infant, Premature, Diseases and Intensive Care Units, Neonatal. Dr. Schultz has published most often in Infect Control Hosp Epidemiol.

CMS Open Payments shows 559 general payments to Dr. Schultz from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Sanofi and Genzyme US Companies paid the most, $2,544.

Dr. Schultz graduated from WesternU College of Osteopathic Medicine of the Pacific in 2002.

Dr. Schultz is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.